SEC 13F Intelligence

Primecap Management Co/Ca/ / NVSN

Primecap Management Co/Ca/’s Novartis AG Position

Does Primecap Management Co/Ca/ own Novartis AG (NVSN)? Yes — 7.57M shares worth $1.2B (+0.91% of its 13F portfolio) as of Q1 2026, down from 7.58M shares the prior filed quarter.

Position Value
$1.2B
Q1 2026
Shares
7.57M
% of Portfolio
+0.91%
Quarters Held
30
currently held

Position History NVSN

Reported value by quarter
Q4 ’18: $2.0BQ4 ’18Q1 ’19: $2.3BQ2 ’19: $2.3BQ3 ’19: $2.2BQ4 ’19: $2.4BQ4 ’19Q1 ’20: $2.0BQ2 ’20: $2.0BQ3 ’20: $2.0BQ4 ’20: $2.1BQ4 ’20Q1 ’21: $1.8BQ2 ’21: $1.8BQ3 ’21: $1.6BQ4 ’21: $1.6BQ4 ’21Q1 ’22: $1.6BQ2 ’22: $1.5BQ3 ’22: $1.3BQ4 ’22: $1.6BQ4 ’22Q1 ’23: $1.5BQ2 ’23: $1.5BQ3 ’23: $1.5BQ4 ’23: $1.3BQ4 ’23Q1 ’24: $1.2BQ2 ’24: $1.3BQ3 ’24: $1.4BQ4 ’24: $1.1BQ4 ’24Q1 ’25: $1.2BQ2 ’25: $1.3BQ3 ’25: $1.2BQ4 ’25: $1.0BQ4 ’25Q1 ’26: $1.2Bfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20267.57M$1.2B+0.91%
Q4 20257.58M$1.0B+0.79%
Q3 20259.34M$1.2B+0.92%
Q2 202510.40M$1.3B+1.00%
Q1 202510.38M$1.2B+0.96%
Q4 202411.03M$1.1B+0.83%
Q3 202412.01M$1.4B+1.02%
Q2 202412.18M$1.3B+0.94%
Q1 202412.42M$1.2B+0.90%
Q4 202312.91M$1.3B+1.03%
Q3 202314.60M$1.5B+1.25%
Q2 202315.01M$1.5B+1.27%
Q1 202316.43M$1.5B+1.32%
Q4 202217.19M$1.6B+1.43%
Q3 202217.45M$1.3B+1.28%
Q2 202217.60M$1.5B+1.33%
Q1 202217.78M$1.6B+1.18%
Q4 202118.17M$1.6B+1.10%
Q3 202119.06M$1.6B+1.10%
Q2 202119.28M$1.8B+1.18%
Q1 202120.54M$1.8B+1.22%
Q4 202021.81M$2.1B+1.53%
Q3 202022.57M$2.0B+1.62%
Q2 202023.27M$2.0B+1.74%
Q1 202024.03M$2.0B+1.94%
Q4 201925.47M$2.4B+1.75%
Q3 201925.54M$2.2B+1.78%
Q2 201925.62M$2.3B+1.73%
Q1 201923.86M$2.3B+1.69%
Q4 201822.89M$2.0B+1.59%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Primecap Management Co/Ca/’s full portfolio or all institutional holders of NVSN.